We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+2.16%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+377.38%
AUM
$881M
AUM Growth
-$121M
Cap. Flow
-$139M
Cap. Flow %
-15.77%
Top 10 Hldgs %
39.5%
Holding
4,106
New
974
Increased
850
Reduced
839
Closed
1,374

Sector Composition

Rank Sector Weight
1 Technology 2.15%
2 Energy 2.14%
3 Industrials 2.11%
4 Financials 2.11%
5 Consumer Discretionary 1.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DXPE icon
1001
DXP Enterprises
DXPE
$2.61B
$30K ﹤0.01%
869
+703
+423% +$25.5K
HDB icon
1002
HDFC Bank
HDB
$122B
$30K ﹤0.01%
1,376
+1,316
+2,193% +$27.5K
INDB icon
1003
Independent Bank
INDB
$4.08B
$30K ﹤0.01%
451
+351
+351% +$22.4K
MCK icon
1004
McKesson
MCK
$103B
$30K ﹤0.01%
+182
New +$27.6K
OLN icon
1005
Olin
OLN
$2.13B
$30K ﹤0.01%
1,000
-1,530
-60% -$46.8K
SEE
1006
DELISTED
Sealed Air
SEE
$30K ﹤0.01%
665
+634
+2,045% +$28K
SLB icon
1007
SLB Ltd
SLB
$74.1B
$30K ﹤0.01%
467
-166
-26% -$11.9K
LUB
1008
DELISTED
Luby's Inc.
LUB
$30K ﹤0.01%
10,617
+1,127
+12% +$3.3K
ATH
1009
DELISTED
Athene Holding Ltd. Class A Common Shares
ATH
$30K ﹤0.01%
600
-361
-38% -$18.5K
TPCO
1010
DELISTED
Tribune Publishing Company Common Stock
TPCO
$30K ﹤0.01%
+2,331
New +$30.2K
CPLA
1011
DELISTED
Capella Education Company
CPLA
$30K ﹤0.01%
352
-340
-49% -$30.2K
CGNT
1012
DELISTED
Cogentix Medical, Inc.
CGNT
$30K ﹤0.01%
17,438
+16,634
+2,069% +$28.5K
BGR icon
1013
BlackRock Energy and Resources Trust
BGR
$402M
$29K ﹤0.01%
+2,200
New +$29.5K
BHP icon
1014
BHP
BHP
$227B
$29K ﹤0.01%
919
-157
-15% -$4.98K
BLBD icon
1015
Blue Bird Corp
BLBD
$2.43B
$29K ﹤0.01%
+1,713
New +$30.9K
CSL icon
1016
Carlisle Companies
CSL
$15.3B
$29K ﹤0.01%
+300
New +$30.3K
DEI icon
1017
Douglas Emmett
DEI
$1.98B
$29K ﹤0.01%
750
-1,728
-70% -$66.6K
FLR icon
1018
Fluor
FLR
$7.04B
$29K ﹤0.01%
638
-2,373
-79% -$114K
GRPN icon
1019
Groupon
GRPN
$1.04B
$29K ﹤0.01%
+380
New +$26.3K
HSIC icon
1020
Henry Schein
HSIC
$10.2B
$29K ﹤0.01%
403
-161
-29% -$11.2K
ICAD
1021
DELISTED
iCAD Inc
ICAD
$29K ﹤0.01%
6,917
+5,960
+623% +$28.7K
LGND icon
1022
Ligand Pharmaceuticals
LGND
$6.06B
$29K ﹤0.01%
+377
New +$26.4K
MAC icon
1023
Macerich
MAC
$7.2B
$29K ﹤0.01%
496
-255
-34% -$15.5K
MKC icon
1024
McCormick & Company Non-Voting
MKC
$14.1B
$29K ﹤0.01%
600
-16
-3% -$810
MX icon
1025
Magnachip Semiconductor
MX
$134M
$29K ﹤0.01%
2,947
-908
-24% -$8.13K

Similar funds

Tower Research Capital (TRC)'s Q2 2017 Portfolio in Review

As of Q2 2017, Tower Research Capital (TRC) held 4,106 positions worth $881M, down 12% from $1B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Tower Research Capital (TRC) withdrew a net $139M in Q2 2017, closing 1,374 positions and reducing 839 holdings. Its most notable exit was State Street SPDR S&P Retail ETF, an estimated $5.29M position sold in full.

By sector, the portfolio is most concentrated in Technology at 2.1% of assets, up from 1.5% a quarter earlier, followed by Energy and Industrials.

Against the trend, Tower Research Capital (TRC) opened a new position in State Street Consumer Discretionary Select Sector SPDR ETF worth $17.2M.

  • Tower Research Capital (TRC)'s largest Q2 2017 buy was State Street Consumer Discretionary Select Sector SPDR ETF: 382,942 shares worth $17.2M.
  • Tower Research Capital (TRC) added most to iShares MSCI Emerging Markets ETF in Q2 2017, an estimated $60M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $152M.
  • Tower Research Capital (TRC) fully exited State Street SPDR S&P Retail ETF in Q2 2017, selling an estimated $5.29M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 40% of its $881M portfolio in Q2 2017.
  • Tower Research Capital (TRC) opened 974 new positions and closed 1,374 in Q2 2017.
  • Tower Research Capital (TRC)'s portfolio value fell 12% quarter-over-quarter to $881M.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2017, filed 15 Aug 2017.